MADISON, Wis., Oct. 14, 2019 /PRNewswire/ -- (NASDAQ: EXAS) – Exact Sciences Corp. today announced that, in collaboration with Mayo Clinic, it has initiated the Voyage study to generate evidence of the real-world impact of Cologuard on colorectal cancer screening, incidence, and mortality rates. Voyage is a prospective, observational study designed to e

NEW YORK and LONDON, Oct. 14, 2019 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R") today announced the appointment of Jean-Luc Belingard, a senior executive with a successful career leading global pharmaceutical businesses, as an Operating Advisor to CD&R Funds. Mr. Belingard will work closely with CD&R's global healthca

STOCKHOLM, Oct. 14, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company") today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance (K190523) to market OssDsign Cranial PSI Accessories in the US. The cleared products are a set of 3D-printed, patient specific accessory devices designed to support and expand clinical use

UPPSALA, Sweden, Oct. 14, 2019 /PRNewswire/ -- The shareholders in Biotage AB (publ), Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the extraordinary general meeting (the "Meeting"), to be held on Thursday, 7 November 2019, at 4pm, at Biotage AB head

ALLENTOWN, Pa., Oct. 14, 2019 /PRNewswire/ -- Yourway, the only truly integrated premium courier and clinical packager in the industry, announced its establishment of a new location within the European Union providing storage and distribution services, including secondary packaging capabilities, located 40 minutes from the

LOS ANGELES, Oct. 14, 2019 /PRNewswire/ -- ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company, today announced the signing of a multi-party collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN), Pfizer Inc. (NYSE: PFE) and Takeda Pharmaceutical Company Limited (Takeda) focused on furthering the clinical development of ImaginAb's CD8 ImmunoPET

SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients in Australia, New Zealand and through

ST. LOUIS, Oct. 12, 2019 /PRNewswire/ -- 2e, an internationally recognized healthcare marketing strategy firm focused on launching pharmaceutical and medical device products, is celebrating a silver win for their CEO, Ross Toohey, at last night's MM&M Awards in New York City.

SAN FRANCISCO, LONDON and TEL AVIV, Israel, Oct. 12, 2019 /PRNewswire/ -- Today the first gl

INDIANAPOLIS, Oct. 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz met co-primary endpoints as well as all major secondary endpoints in a Phase 3 study in pediatric patients with moderate to severe plaque psoriasis, demonstrating that 89 percent of patients treated with Taltz achieved a significant 75 percent improvement from baselin